Samsung Biologics CEO John Lim “Leap as a global bio company through intensive investment”
Samsung Biologics CEO John Lim speaks at the general shareholders’ meeting. Source = Samsung Biologics John Lim, CEO of Samsung Biologics (207940), emphasized that this year’s investment will make it a global bio company. Samsung Biologics held the 11th regular general meeting of shareholders at Incheon Global Campus located in Yeonsu-gu, Incheon on the 29th. … Read more